About Us
Vision
R$ Team
R$ Advisory Group
News
Policy & Regulation
Science & Technology
Innovation & Investment
The Short Report
Voices
Conferences & Events
Upcoming Events
Past Events
Partner With Us
Membership
Advertise
Contact
Login
Mentions: Patented Medicines Prices Review Board
Title
Date
Author
Pharma companies urge Ottawa to postpone changes to lower drug prices to next year
May 20, 2020
Debbie Lawes
Pharmaceutical R&D spending remains far below industry’s 10% commitment – PMPRB report
December 13, 2017
Mark Henderson
Generic drug report attacks brand-name industry
November 11, 2013
Guest Contributor
Top
Title
×
TBD
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our
Privacy Policy
and
Terms of Service
.
OK